Your browser doesn't support javascript.
loading
Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study.
Tang, Gilbert H L; Spencer, Julianne; Rogers, Toby; Grubb, Kendra J; Gleason, Patrick; Gada, Hemal; Mahoney, Paul; Dauerman, Harold L; Forrest, John K; Reardon, Michael J; Blanke, Philipp; Leipsic, Jonathon A; Abdel-Wahab, Mohamed; Attizzani, Guilherme F; Puri, Rishi; Caskey, Michael; Chung, Christine J; Chen, Ying-Hwa; Dudek, Dariusz; Allen, Keith B; Chhatriwalla, Adnan K; Htun, Wah Wah; Blackman, Daniel J; Tarantini, Giuseppe; Zhingre Sanchez, Jorge; Schwartz, Greta; Popma, Jeffrey J; Sathananthan, Janarthanan.
Afiliação
  • Tang GHL; Department of Cardiovascular Surgery, Mount Sinai Health System, New York (G.H.L.T.).
  • Spencer J; Structural Heart & Aortic, Medtronic, Mounds View, MN (J. Spencer, J.Z.S., G.S., J.J.P.).
  • Rogers T; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington DC (T.R.).
  • Grubb KJ; Division of Cardiothoracic Surgery (K.J.G.), Emory University, Atlanta, GA.
  • Gleason P; Structural Heart and Valve Center (K.J.G., P.G.), Emory University, Atlanta, GA.
  • Gada H; Structural Heart and Valve Center (K.J.G., P.G.), Emory University, Atlanta, GA.
  • Mahoney P; Division of Cardiology (P.G.), Emory University, Atlanta, GA.
  • Dauerman HL; University of Pittsburgh Medical Center Pinnacle Health, PA (H.G.).
  • Forrest JK; Sentara Heart Hospital, Norfolk, VA (P.M.).
  • Reardon MJ; University of Vermont Larner College of Medicine, Burlington (H.L.D.).
  • Blanke P; Division of Cardiology, Yale School of Medicine, New Haven, CT (J.K.F.).
  • Leipsic JA; Department of Cardiovascular Surgery, Houston Methodist, TX (M.J.R.).
  • Abdel-Wahab M; Center for Heart Valve Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, Canada (P.B., J.A.L.).
  • Attizzani GF; Center for Heart Valve Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, Canada (P.B., J.A.L.).
  • Puri R; Heart Center Leipzig at University of Leipzig, Germany (M.A.-W.).
  • Caskey M; Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, OH (G.F.A.).
  • Chung CJ; Cleveland Clinic, OH (R.P.).
  • Chen YH; Abrazo Arizona Heart Hospital, Phoenix (M.C.).
  • Dudek D; Division of Cardiology, University of Washington Medical Center, Seattle (C.J.C.).
  • Allen KB; Division of Cardiology, Department of Internal Medicine, Taipei Veterans General Hospital, Taiwan (Y.-H.C.).
  • Chhatriwalla AK; Jagiellonian University Medical College, Krakow, Poland (D.D.).
  • Htun WW; St. Luke's Mid America Heart Institute, Kansas City, MO (K.B.A., A.K.C.).
  • Blackman DJ; St. Luke's Mid America Heart Institute, Kansas City, MO (K.B.A., A.K.C.).
  • Tarantini G; Gundersen Health System, La Crosse, WI (W.W.H.).
  • Zhingre Sanchez J; Department of Cardiology, Leeds Teaching Hospitals, Leeds, United Kingdom (D.J.B.).
  • Schwartz G; Thoracic, Vascular Sciences and Public Health, University of Padua Medical School, Italy (G.T.).
  • Popma JJ; Structural Heart & Aortic, Medtronic, Mounds View, MN (J. Spencer, J.Z.S., G.S., J.J.P.).
  • Sathananthan J; Structural Heart & Aortic, Medtronic, Mounds View, MN (J. Spencer, J.Z.S., G.S., J.J.P.).
Circ Cardiovasc Interv ; 16(11): e013238, 2023 11.
Article em En | MEDLINE | ID: mdl-37988439
ABSTRACT

BACKGROUND:

Coronary accessibility following redo-transcatheter aortic valve replacement (redo-TAVR) is increasingly important, particularly in younger low-risk patients. This study aimed to predict coronary accessibility after simulated Sapien-3 balloon-expandable valve implantation within an Evolut supra-annular, self-expanding valve using pre-TAVR computed tomography (CT) imaging.

METHODS:

A total of 219 pre-TAVR CT scans from the Evolut Low-Risk CT substudy were analyzed. Virtual Evolut and Sapien-3 valves were sized using CT-based diameters. Two initial Evolut implant depths were analyzed, 3 and 5 mm. Coronary accessibility was evaluated for 2 Sapien-3 in Evolut implant positions Sapien-3 outflow at Evolut node 4 and Evolut node 5.

RESULTS:

With a 3-mm initial Evolut implant depth, suitable coronary access was predicted in 84% of patients with the Sapien-3 outflow at Evolut node 4, and in 31% of cases with the Sapien-3 outflow at Evolut node 5 (P<0.001). Coronary accessibility improved with a 5-mm Evolut implant depth 97% at node 4 and 65% at node 5 (P<0.001). When comparing 3- to 5-mm Evolut implant depth, sinus sequestration was the lowest with Sapien-3 outflow at Evolut node 4 (13% versus 2%; P<0.001), and the highest at Evolut node 5 (61% versus 32%; P<0.001).

CONCLUSIONS:

Coronary accessibility after Sapien-3 in Evolut redo-TAVR relates to the initial Evolut implant depth, the Sapien-3 outflow position within the Evolut, and the native annular anatomy. This CT-based quantitative analysis may provide useful information to inform and refine individualized preprocedural CT planning of the initial TAVR and guide lifetime management for future coronary access after redo-TAVR. REGISTRATION URL https//www.clinicaltrials.gov; Unique identifier NCT02701283.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estenose da Valva Aórtica / Próteses Valvulares Cardíacas / Substituição da Valva Aórtica Transcateter Limite: Humans Idioma: En Revista: Circ Cardiovasc Interv Assunto da revista: ANGIOLOGIA / CARDIOLOGIA Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estenose da Valva Aórtica / Próteses Valvulares Cardíacas / Substituição da Valva Aórtica Transcateter Limite: Humans Idioma: En Revista: Circ Cardiovasc Interv Assunto da revista: ANGIOLOGIA / CARDIOLOGIA Ano de publicação: 2023 Tipo de documento: Article